First Mercantile Trust’s ALX Oncology ALXO Stock Holding History

First Mercantile Trust’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$105K	Sell	1,428 -93	-6%	-$6.2K	0.01%	642
2021 Q2	$83K	Buy	1,521 +117	+8%	+$7K	0.01%	732
2021 Q1	$104K	Buy	1,404 +195	+16%	+$15.3K	0.01%	669
2020 Q4	$104K	Buy	1,209 +609	+102%	+$36.6K	0.01%	676
2020 Q3	$28K	Buy	+600	New	+$23.6K	﹤0.01%	820

Other funds holding ALXO

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

First Mercantile Trust's ALXO Position: Q3 2021 in Review

First Mercantile Trust reduced its ALX Oncology (ALXO) stake by 6.1% in Q3 2021, selling an estimated $6.2K and leaving 1,428 shares worth $105K. The position accounts for 0.01% of the portfolio, ranked #642.

First Mercantile Trust first reported a position in ALXO in Q3 2020 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold ALXO as of Q3 2021.

First Mercantile Trust held 1,428 shares of ALX Oncology worth $105K as of Q3 2021.
First Mercantile Trust sold 93 ALX Oncology shares in Q3 2021, an estimated $6.2K.
ALX Oncology made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #642 holding.
First Mercantile Trust first reported a position in ALX Oncology in Q3 2020 and has held it in 5 quarters since.
114 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.